verapamil has been researched along with Auricular Flutter in 103 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Efficacy and safety of intravenous flecainide (2 mg/kg body weight in 10 minutes), verapamil (10 mg in 1 minute), and propafenone (2 mg/kg body weight in 10 minutes) were investigated in 90 consecutive patients with atrial fibrillation (AF) or flutter (AFL)." | 9.07 | Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. ( Kingma, JH; Suttorp, MJ, 1992) |
| "The effects of esmolol, an ultrashort-acting beta blocker, and verapamil were compared in controlling ventricular response in 45 patients with atrial fibrillation or atrial flutter, in a randomized, parallel, open-label study." | 9.06 | Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. ( Das, G; Michelson, EL; Platia, EV; Porterfield, JK, 1989) |
| "In a single-blind randomized study, the efficacy of intravenous flecainide (2 mg/kg/10 minutes) versus verapamil (10 mg/1 minute) was assessed in 40 patients with paroxysmal atrial fibrillation (AF) or atrial flutter (AFI)." | 9.06 | Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. ( Kingma, JH; Lie-A-Huen, L; Mast, EG; Suttorp, MJ, 1989) |
| "The safety and efficacy of oral verapamil to control exercise tachycardia in 27 patients with atrial fibrillation and 3 with atrial flutter receiving digitalis was evaluated in a double-blind, randomized, crossover study." | 9.05 | Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis. ( Baessler, C; Morganroth, J; Panidis, IP, 1983) |
| "The safety and efficacy of the intravenous (IV) calcium channel blocker, verapamil, in controlling the ventricular response or converting to sinus rhythm patients with atrial flutter or atrial fibrillation were assessed." | 9.05 | Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil. ( McDonough, T; Parker, M; Talano, JV; Tommaso, C, 1983) |
| "The effectiveness of verapamil in controlling ventricular rate was evaluated in 20 patients with atrial fibrillation or flutter with a rapid ventricular response (Group 1) and 30 patients with paroxysmal supraventricular tachycardia (Group 2)." | 9.05 | Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. ( Appel, R; Myerburg, RJ; Sung, RJ; Waxman, HL, 1981) |
| " Verapamil remains the most widely used calcium antagonist for the treatment of cardiac arrhythmias." | 8.76 | Verapamil in cardiac arrhythmias: an overview. ( Vohra, J, 1982) |
| "It is clear from clinical and experimental data that have been reported thus far that verapamil is highly effective in the therapy of cardiac arrhythmias, and that it acts by a different mechanism than most of the commonly used antiarrhythmic drugs." | 8.75 | Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. ( Hoffman, BF; Rosen, MR; Wit, AL, 1975) |
| "We studied retrospectively 102 patients, 76 males, 26 females, mean age 56 +/- 12 years, with paroxysmal or sustained atrial fibrillation or atrial flutter (AFlut) treated with verapamil/quinidine (Cordichin) (dosage 3 to 5 times 1 tablet/day)." | 7.69 | [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine]. ( Pfitzner, P; Trappe, HJ, 1996) |
| "The antiarrhythmic properties of sublingual verapamil were investigated in seven patients with acute fast atrial flutter (n = 2) or fibrillation (n = 5)." | 7.69 | Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter. ( Fort, S; John, DN; Lewis, MJ; Luscombe, DK, 1994) |
| "To compare the direct effects of verapamil and diltiazem on the ventricular rate during atrial flutter, we developed an atrial flutter model in guinea pig isolated hearts." | 7.69 | Effects of verapamil and diltiazem on the ventricular rate during simulated atrial flutter in isolated guinea pig hearts. ( Belardinelli, L; Decrinis, M; Domanovits, H; Kasper, K; Stark, G; Stark, U; Sterz, F; Tritthart, HA, 1996) |
| "In a patient with ischaemic heart disease chronic atrial flutter reverted to sinus rhythm during treatment with oral Verapamil, given at dosage of 240 mg once a day in order to prevent spontaneous angina." | 7.67 | Conversion of longstanding atrial flutter to sinus rhythm and transient complete A-V block following oral administration of verapamil. Report of a case. ( Di Giacomo, M; Di Giacomo, V; Tedeschi, A, 1984) |
| " We report a patient with atrial flutter-fibrillation who developed cyclic sinus node dysfunction with profound ventricular pauses in response to small doses of digoxin, verapamil, and propranolol, which resolved with discontinuation of the medications." | 7.67 | Hyperthyroid-induced atrial flutter-fibrillation with profound sinoatrial nodal pauses due to small doses of digoxin, verapamil, and propranolol. ( Hurst, JW; Talley, JD; Wathen, MS, 1989) |
| "Certain general conclusions suggest themselves on the basis of our extensive experience with treating arrhythmias in patients following open heart surgery, our specific results with verapamil therapy in the treatment of atrial fibrillation and atrial flutter in patients following open heart surgery, and the results of verapamil therapy administered in other groups of patients." | 7.66 | Verapamil therapy in the treatment of supraventricular arrhythmias following open heart surgery. ( Arciniegas, JG; Henthorn, RW; Plumb, VJ; Waldo, AL; Zimmern, SH, 1983) |
| "The acute effect of verapamil on the ventricular rate in atrial fibrillation and flutter was studied in 15 patients, 13 of whom had heart rate inadequately controlled with digitalis." | 7.66 | Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter. ( Dominic, J; Kuo, CS; McAllister, RG; Reddy, CP; Surawicz, B, 1979) |
| "The effects of intravenous verapamil on the electrocardiogram in 15 patients with heart disease in sinus rhythm and in 44 patients with supraventricular and ventricular tachyarrhythmias were evaluated." | 7.65 | Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. ( Heng, MK; Mercer, CJ; Norris, RM; Roche, AH; Singh, BN, 1975) |
| "Verapamil caused a lower ventricular rate, but only six (19%) of the patients (n = 31) converted to sinus rhythm within 4 h (p < 0." | 6.67 | The effect of magnesium versus verapamil on supraventricular arrhythmias. ( Birkeland, K; Gullestad, L; Høyer, MM; Kjekshus, J; Mølstad, P; Vanberg, P, 1993) |
| "Verapamil has become a popular antiarrhythmic drug for the acute management of supraventricular tachycardia in infants and children." | 5.27 | Successful management of atrial flutter in a newborn with verapamil. ( Casta, A; Richardson, CJ; Sapire, DW; Wolf, WJ, 1985) |
| "Efficacy and safety of intravenous flecainide (2 mg/kg body weight in 10 minutes), verapamil (10 mg in 1 minute), and propafenone (2 mg/kg body weight in 10 minutes) were investigated in 90 consecutive patients with atrial fibrillation (AF) or flutter (AFL)." | 5.07 | Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. ( Kingma, JH; Suttorp, MJ, 1992) |
| "The effects of esmolol, an ultrashort-acting beta blocker, and verapamil were compared in controlling ventricular response in 45 patients with atrial fibrillation or atrial flutter, in a randomized, parallel, open-label study." | 5.06 | Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. ( Das, G; Michelson, EL; Platia, EV; Porterfield, JK, 1989) |
| "In a single-blind randomized study, the efficacy of intravenous flecainide (2 mg/kg/10 minutes) versus verapamil (10 mg/1 minute) was assessed in 40 patients with paroxysmal atrial fibrillation (AF) or atrial flutter (AFI)." | 5.06 | Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. ( Kingma, JH; Lie-A-Huen, L; Mast, EG; Suttorp, MJ, 1989) |
| "The safety and efficacy of oral verapamil to control exercise tachycardia in 27 patients with atrial fibrillation and 3 with atrial flutter receiving digitalis was evaluated in a double-blind, randomized, crossover study." | 5.05 | Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis. ( Baessler, C; Morganroth, J; Panidis, IP, 1983) |
| "The safety and efficacy of the intravenous (IV) calcium channel blocker, verapamil, in controlling the ventricular response or converting to sinus rhythm patients with atrial flutter or atrial fibrillation were assessed." | 5.05 | Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil. ( McDonough, T; Parker, M; Talano, JV; Tommaso, C, 1983) |
| "The effectiveness of verapamil in controlling ventricular rate was evaluated in 20 patients with atrial fibrillation or flutter with a rapid ventricular response (Group 1) and 30 patients with paroxysmal supraventricular tachycardia (Group 2)." | 5.05 | Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. ( Appel, R; Myerburg, RJ; Sung, RJ; Waxman, HL, 1981) |
| " Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease." | 4.77 | Calcium antagonists in patients with cardiovascular disease. Current perspectives. ( Hillis, LD; Winniford, MD, 1985) |
| " Verapamil remains the most widely used calcium antagonist for the treatment of cardiac arrhythmias." | 4.76 | Verapamil in cardiac arrhythmias: an overview. ( Vohra, J, 1982) |
| "It is clear from clinical and experimental data that have been reported thus far that verapamil is highly effective in the therapy of cardiac arrhythmias, and that it acts by a different mechanism than most of the commonly used antiarrhythmic drugs." | 4.75 | Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. ( Hoffman, BF; Rosen, MR; Wit, AL, 1975) |
| " The aim of this study was to investigate the efficacy of the novel Ca2+ antagonist semotiadil compared with verapamil and diltiazem on the filtering capacity of the AV node during simulated atrial flutter in isolated guinea-pig hearts perfused by the method of Langendorff." | 3.70 | Efficacy of the novel calcium antagonist R(+)-semotiadil in limiting the ventricular rate during atrial flutter in isolated guinea pig hearts. ( Brodmann, M; Haiden, U; Schwarzl, I; Stark, G; Stark, U; Tritthart, HA, 2000) |
| "We studied retrospectively 102 patients, 76 males, 26 females, mean age 56 +/- 12 years, with paroxysmal or sustained atrial fibrillation or atrial flutter (AFlut) treated with verapamil/quinidine (Cordichin) (dosage 3 to 5 times 1 tablet/day)." | 3.69 | [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine]. ( Pfitzner, P; Trappe, HJ, 1996) |
| "To compare the direct effects of verapamil and diltiazem on the ventricular rate during atrial flutter, we developed an atrial flutter model in guinea pig isolated hearts." | 3.69 | Effects of verapamil and diltiazem on the ventricular rate during simulated atrial flutter in isolated guinea pig hearts. ( Belardinelli, L; Decrinis, M; Domanovits, H; Kasper, K; Stark, G; Stark, U; Sterz, F; Tritthart, HA, 1996) |
| "The antiarrhythmic properties of sublingual verapamil were investigated in seven patients with acute fast atrial flutter (n = 2) or fibrillation (n = 5)." | 3.69 | Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter. ( Fort, S; John, DN; Lewis, MJ; Luscombe, DK, 1994) |
| "Nineteen consecutive patients with atrial fibrillation/flutter or other types of supraventricular tachycardia were given intravenous (IV) calcium salts (1 g) followed by verapamil infusion at a rate of 1 mg/min." | 3.68 | Short-term control of supraventricular tachycardia with verapamil infusion and calcium pretreatment. ( Barnett, JC; Touchon, RC, 1990) |
| "In a patient with ischaemic heart disease chronic atrial flutter reverted to sinus rhythm during treatment with oral Verapamil, given at dosage of 240 mg once a day in order to prevent spontaneous angina." | 3.67 | Conversion of longstanding atrial flutter to sinus rhythm and transient complete A-V block following oral administration of verapamil. Report of a case. ( Di Giacomo, M; Di Giacomo, V; Tedeschi, A, 1984) |
| " We report a patient with atrial flutter-fibrillation who developed cyclic sinus node dysfunction with profound ventricular pauses in response to small doses of digoxin, verapamil, and propranolol, which resolved with discontinuation of the medications." | 3.67 | Hyperthyroid-induced atrial flutter-fibrillation with profound sinoatrial nodal pauses due to small doses of digoxin, verapamil, and propranolol. ( Hurst, JW; Talley, JD; Wathen, MS, 1989) |
| "Intravenous verapamil hydrochloride was used alone in 63 episodes of atrial fibrillation and flutter and six episodes of supraventricular tachycardia (SVT) (group A)." | 3.67 | Treatment of atrial arrhythmias. Effectiveness of verapamil when preceded by calcium infusion. ( Habbab, MA; Haft, JI, 1986) |
| "The acute effect of verapamil on the ventricular rate in atrial fibrillation and flutter was studied in 15 patients, 13 of whom had heart rate inadequately controlled with digitalis." | 3.66 | Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter. ( Dominic, J; Kuo, CS; McAllister, RG; Reddy, CP; Surawicz, B, 1979) |
| "The effectiveness and lack of undesirable side-effects has made Verapamil the drug of choice in the treatment of paroxysmal supraventricular tachycardia in infants without underlying heart disease." | 3.66 | A hemodynamic complication of verapamil therapy in a neonate. ( Abinader, E; Berger, A; Borochowitz, Z, 1981) |
| ", verapamil, disopyramide, and procainamide, on paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (Af) and atrial flutter (AF) were evaluated electrophysiologically." | 3.66 | Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias. ( Hiejima, K; Satake, S; Suzuki, F; Takahashi, M, 1983) |
| "Forty-nine consecutive patients (44 with atrial fibrillation and five with atrial flutter) received 10 mg of verapamil five to seven minutes before elective electroversion, to evaluate the feasibility of the latter while verapamil effects were present." | 3.66 | Electroversion after verapamil administration. ( Larrousse, E; Noguera, L; Permanyer-Miralda, G; Sagristá-Sauleda, J; Soler-Soler, J; Tornos, MP, 1983) |
| "Certain general conclusions suggest themselves on the basis of our extensive experience with treating arrhythmias in patients following open heart surgery, our specific results with verapamil therapy in the treatment of atrial fibrillation and atrial flutter in patients following open heart surgery, and the results of verapamil therapy administered in other groups of patients." | 3.66 | Verapamil therapy in the treatment of supraventricular arrhythmias following open heart surgery. ( Arciniegas, JG; Henthorn, RW; Plumb, VJ; Waldo, AL; Zimmern, SH, 1983) |
| "Personal clinical experience using Verapamil intravenously in 200 patients with a number of arrhythmia conditions is reported." | 3.65 | [Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration]. ( Malfatti, S; Piccini, A, 1975) |
| "The effects of intravenous verapamil on the electrocardiogram in 15 patients with heart disease in sinus rhythm and in 44 patients with supraventricular and ventricular tachyarrhythmias were evaluated." | 3.65 | Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. ( Heng, MK; Mercer, CJ; Norris, RM; Roche, AH; Singh, BN, 1975) |
| "Verapamil administered by the intravenous route restored sinus rhythm in 33 out of 40 episodes of supraventricular tachycardia." | 3.65 | Clinical experience with verapamil. ( Hunt, D; Sloman, G; Vohra, J, 1975) |
| "Rapid and slow venous infusion of various doses of Verapamil in a mixed series of 185 cases of arrhythmia since 1968 is reported." | 3.65 | [Anti-arrhythmic therapy with verapamil by intravenous infusion]. ( Disertori, M; Furlanello, F; Lanzetta, T; Piccolo, E; Trevi, GP, 1975) |
| "The occurrence of paroxysmal atrial fibrillation is documented by transtelephonic ECG monitoring." | 2.69 | [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians]. ( Koch, HP; Lüderitz, B; Meinertz, T; Patten, M; Sonntag, F, 1999) |
| "Verapamil caused a lower ventricular rate, but only six (19%) of the patients (n = 31) converted to sinus rhythm within 4 h (p < 0." | 2.67 | The effect of magnesium versus verapamil on supraventricular arrhythmias. ( Birkeland, K; Gullestad, L; Høyer, MM; Kjekshus, J; Mølstad, P; Vanberg, P, 1993) |
| "When amiodarone was not employed, as a first choice, in conformity with a specific protocol, it was utilized as a second choice after verapamil or flecainide." | 1.28 | [Supraventricular tachyarrhythmia of recent onset in the absence of documented cardiac pathology: different therapeutic approaches]. ( Bechi, S; Cordoni, M; Franchini, C; Mazza, F; Micheli, G; Scalzini, A, 1989) |
| "Verapamil has become a popular antiarrhythmic drug for the acute management of supraventricular tachycardia in infants and children." | 1.27 | Successful management of atrial flutter in a newborn with verapamil. ( Casta, A; Richardson, CJ; Sapire, DW; Wolf, WJ, 1985) |
| "In this age group most of the occurring cardiac arrhythmias are harmless and pass without serious circulatory disturbances." | 1.25 | [Treatment of heart-rhythm disorders in infancy and childhood]. ( Eschenbacher, HL; Gutheil, H; Singer, H, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 80 (77.67) | 18.7374 |
| 1990's | 15 (14.56) | 18.2507 |
| 2000's | 5 (4.85) | 29.6817 |
| 2010's | 2 (1.94) | 24.3611 |
| 2020's | 1 (0.97) | 2.80 |
| Authors | Studies |
|---|---|
| Rajput, FA | 1 |
| Du, L | 1 |
| Chappell, RJ | 1 |
| Berei, TJ | 1 |
| Goldberger, ZD | 1 |
| Wright, JM | 1 |
| Monsel, F | 1 |
| El Hraiech, A | 1 |
| Amara, W | 1 |
| Sacha, J | 1 |
| Barabach, S | 1 |
| Feusette, P | 1 |
| Kukla, P | 1 |
| Khan, IA | 2 |
| Peters, RW | 1 |
| Theisen, K | 1 |
| Lander, R | 1 |
| Willoughby, ML | 1 |
| Dunlap, DB | 1 |
| Gmeiner, R | 1 |
| Sterz, H | 1 |
| Frishman, WH | 1 |
| LeJemtel, TH | 1 |
| von Bock, U | 1 |
| Zipes, DP | 3 |
| Gilmour, RF | 2 |
| Zalman, F | 1 |
| Perloff, JK | 1 |
| Durant, NN | 1 |
| Campion, DS | 1 |
| Singh, BN | 2 |
| Nademanee, K | 1 |
| Feld, G | 1 |
| Panidis, IP | 1 |
| Morganroth, J | 1 |
| Baessler, C | 1 |
| Di Giacomo, V | 1 |
| Tedeschi, A | 1 |
| Di Giacomo, M | 1 |
| Dick, M | 1 |
| Campbell, RM | 1 |
| Waldo, AL | 2 |
| Plumb, VJ | 2 |
| Arciniegas, JG | 1 |
| Henthorn, RW | 1 |
| Zimmern, SH | 1 |
| Tommaso, C | 1 |
| McDonough, T | 1 |
| Parker, M | 1 |
| Talano, JV | 1 |
| Vohra, J | 2 |
| Beck, OA | 2 |
| Günther, R | 2 |
| Hochrein, H | 2 |
| Soler-Soler, J | 1 |
| Permanyer-Miralda, G | 1 |
| Sagristá-Sauleda, J | 1 |
| Noguera, L | 1 |
| Larrousse, E | 1 |
| Tornos, MP | 1 |
| Hiejima, K | 1 |
| Suzuki, F | 1 |
| Takahashi, M | 1 |
| Satake, S | 1 |
| Uzilevskaia, RA | 1 |
| Grishkin, IuN | 1 |
| Wu, D | 1 |
| Schamroth, L | 1 |
| Aronow, WS | 2 |
| Ferlinz, J | 1 |
| Sung, RJ | 2 |
| Waxman, HL | 2 |
| Elser, B | 1 |
| Juma, Z | 1 |
| Karp, RB | 1 |
| Kouchoukos, NT | 1 |
| Zorn, GL | 1 |
| James, TN | 1 |
| Abinader, E | 1 |
| Borochowitz, Z | 1 |
| Berger, A | 1 |
| Rabkin, SW | 1 |
| Tomlinson, C | 1 |
| Corbett, BN | 1 |
| Cuddy, TE | 1 |
| Rinkenberger, RL | 1 |
| Prystowsky, EN | 1 |
| Heger, JJ | 1 |
| Troup, PJ | 1 |
| Jackman, WM | 1 |
| Myerburg, RJ | 1 |
| Appel, R | 1 |
| Ben Zemenick, R | 2 |
| van den Berg, MP | 1 |
| Crijns, HJ | 1 |
| Szabó, BM | 1 |
| Brouwer, J | 1 |
| Lie, KI | 1 |
| Fort, S | 1 |
| Lewis, MJ | 1 |
| Luscombe, DK | 1 |
| John, DN | 1 |
| Manz, M | 1 |
| Lüderitz, B | 2 |
| Carmona, J | 1 |
| Amado, P | 1 |
| Castanheira, J | 1 |
| Nazaré, J | 1 |
| Araújo, V | 1 |
| Gullestad, L | 1 |
| Birkeland, K | 1 |
| Mølstad, P | 1 |
| Høyer, MM | 1 |
| Vanberg, P | 1 |
| Kjekshus, J | 1 |
| Joshi, PP | 1 |
| Deshmukh, PK | 1 |
| Salkar, RG | 1 |
| Stark, U | 2 |
| Stark, G | 2 |
| Kasper, K | 1 |
| Decrinis, M | 1 |
| Domanovits, H | 1 |
| Sterz, F | 1 |
| Belardinelli, L | 1 |
| Tritthart, HA | 2 |
| Trappe, HJ | 1 |
| Pfitzner, P | 1 |
| Orlov, YS | 1 |
| Brodsky, MA | 1 |
| Orlov, MV | 1 |
| Allen, B | 1 |
| Patten, M | 1 |
| Koch, HP | 1 |
| Sonntag, F | 1 |
| Meinertz, T | 1 |
| Schwarzl, I | 1 |
| Brodmann, M | 1 |
| Haiden, U | 1 |
| Naccarelli, GV | 1 |
| Dell'Orfano, JT | 1 |
| Wolbrette, DL | 1 |
| Patel, HM | 1 |
| Luck, JC | 1 |
| Trohman, RG | 1 |
| Donaldson, RM | 1 |
| Piccini, A | 1 |
| Malfatti, S | 1 |
| Klein, W | 1 |
| Brochier, M | 1 |
| Fauchier, JP | 1 |
| Marsocci, G | 1 |
| Giordano, F | 1 |
| Manai, L | 1 |
| Todini, AR | 1 |
| Artizzu, G | 1 |
| De Benedictis, F | 1 |
| Donnangelo, L | 1 |
| Sica, G | 1 |
| Ghidichimo, G | 1 |
| Musto, B | 1 |
| Greco, R | 1 |
| Calabrò, R | 1 |
| Marsico, F | 1 |
| Dominic, J | 1 |
| McAllister, RG | 1 |
| Kuo, CS | 1 |
| Reddy, CP | 1 |
| Surawicz, B | 1 |
| Anshelevich, IuV | 1 |
| Sorokina, TA | 1 |
| Bekere, FA | 1 |
| Slaĭdyn', AK | 1 |
| Beer, ET | 1 |
| Carvalho, MA | 1 |
| Osterne, EC | 1 |
| Bezerra, FA | 1 |
| Carvalho, PR | 1 |
| Barros, RB | 1 |
| Carneiro, RD | 1 |
| Farup, PG | 1 |
| Chaudron, JM | 1 |
| Lebacq, E | 1 |
| Rosen, MR | 1 |
| Wit, AL | 1 |
| Hoffman, BF | 1 |
| Furlanello, F | 1 |
| Piccolo, E | 1 |
| Disertori, M | 1 |
| Trevi, GP | 1 |
| Lanzetta, T | 1 |
| Heng, MK | 1 |
| Roche, AH | 1 |
| Norris, RM | 1 |
| Mercer, CJ | 1 |
| Hunt, D | 1 |
| Sloman, G | 1 |
| Singer, H | 1 |
| Eschenbacher, HL | 1 |
| Gutheil, H | 1 |
| Lipnitskiĭ, TN | 1 |
| Denisiuk, VI | 1 |
| Kolesnik, PF | 1 |
| Stoliarchuk, VA | 1 |
| Sizova, MP | 1 |
| Kingma, JH | 2 |
| Suttorp, MJ | 2 |
| Barnett, JC | 1 |
| Touchon, RC | 1 |
| Lie-A-Huen, L | 1 |
| Mast, EG | 1 |
| Cordoni, M | 1 |
| Scalzini, A | 1 |
| Bechi, S | 1 |
| Franchini, C | 1 |
| Mazza, F | 1 |
| Micheli, G | 1 |
| Platia, EV | 1 |
| Michelson, EL | 1 |
| Porterfield, JK | 1 |
| Das, G | 1 |
| Vainer, J | 1 |
| Smíd, J | 1 |
| Cepeláková, H | 1 |
| Hapala, J | 1 |
| Topinka, I | 1 |
| Topolcan, O | 1 |
| Talley, JD | 1 |
| Wathen, MS | 1 |
| Hurst, JW | 1 |
| Bayés de Luna, A | 1 |
| Oter, MC | 1 |
| Guindo, J | 1 |
| Vintzileos, AM | 1 |
| Campbell, WA | 1 |
| Soberman, SM | 1 |
| Nochimson, DJ | 1 |
| Klein, HO | 1 |
| Kaplinsky, E | 1 |
| Keefe, DL | 1 |
| Miura, D | 1 |
| Somberg, JC | 1 |
| Gautam, CS | 1 |
| Lal, R | 1 |
| Pandhi, P | 1 |
| Sharma, PL | 1 |
| Haft, JI | 1 |
| Habbab, MA | 1 |
| Del Negro, AA | 1 |
| Fletcher, RD | 1 |
| Winniford, MD | 1 |
| Hillis, LD | 1 |
| Smith, EE | 1 |
| Shore, DF | 1 |
| Monro, JL | 1 |
| Ross, JK | 1 |
| Cummings, P | 1 |
| Podolsky, SM | 1 |
| Waninger, K | 1 |
| Wertheimer, J | 1 |
| Casta, A | 1 |
| Wolf, WJ | 1 |
| Richardson, CJ | 1 |
| Sapire, DW | 1 |
| Hardewig, A | 1 |
| Diedrich, R | 1 |
| Antani, JA | 1 |
| Sriniwas, HV | 1 |
| Kock, R | 1 |
| Kaufmann, G | 1 |
| Chatillon, J | 1 |
| Barousch, R | 1 |
| Bender, F | 2 |
| Doshchitsyn, VL | 1 |
| Arshakuni, RO | 1 |
| Zharov, EI | 1 |
| Bühlmeyer, K | 1 |
| Lang-Krebs, T | 1 |
| Gotsman, MS | 1 |
| Lewis, BS | 1 |
| Bakst, A | 1 |
| Mitha, AS | 1 |
| Slome, R | 1 |
| Filias, N | 1 |
| Zanoni, G | 1 |
| Bass, O | 1 |
| Friedemann, M | 1 |
| Betz, GG | 1 |
| Olesch, K | 1 |
| Schmidt-Voigt, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparism Between Efficacy and Effectiveness Between Slow Infusion of Calcium Channel Blockers and Intravenous Bolus Adenosine in the Management of Supraventricular Tachycardia in the Emergency Department.[NCT00413712] | Phase 4 | 206 participants | Interventional | 1997-01-31 | Completed | ||
| Calcium Administration to Prevent Hypotension Caused by Diltiazem Administration in the Treatment of Atrial Fibrillation With Rapid Ventricular Response[NCT05691959] | Phase 2 | 378 participants (Anticipated) | Interventional | 2023-01-26 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for verapamil and Auricular Flutter
| Article | Year |
|---|---|
Atrial stunning: basics and clinical considerations.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function; Atrial Functi | 2003 |
Verapamil/beta-blocker interaction. A review.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Atrial Flutter; Calcium; Drug Interactions; | 1983 |
The treatment of atrial fibrillation and flutter: a review.
Topics: Adrenergic beta-Antagonists; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Ar | 1984 |
Calcium antagonists and their potential role in the prevention of sudden coronary death.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Calcium Chan | 1982 |
Management of arrhythmias with "calcium antagonists".
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Calcium; Calcium C | 1982 |
Antiarrhythmic effects of verapamil.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; At | 1983 |
Verapamil in cardiac arrhythmias: an overview.
Topics: Administration, Oral; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blo | 1982 |
The clinical use of intravenous verapamil.
Topics: Angina Pectoris, Variant; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atrioventricula | 1980 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Fle | 1993 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit An | 2000 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiogra | 2000 |
Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Appendage; Atrial Fibrillation; Atrial | 2002 |
Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.
Topics: Action Potentials; Administration, Oral; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial | 1975 |
Management of supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Huma | 1989 |
Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?
Topics: Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Digitalis Glycosides; Drug Therapy, Comb | 1986 |
Supraventricular tachyarrhythmias: their evaluation and therapy.
Topics: Acute Disease; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers | 1986 |
Calcium antagonists in patients with cardiovascular disease. Current perspectives.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardio | 1985 |
[Heart rhythm disorders during pacemaker therapy].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Electricity | 1973 |
[Anti-arrhythmia agents].
Topics: Action Potentials; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atri | 1974 |
15 trials available for verapamil and Auricular Flutter
| Article | Year |
|---|---|
Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis.
Topics: Administration, Oral; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Clinical Tr | 1983 |
Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Double-Blind Method; Drug Evaluati | 1983 |
Verapamil versus placebo in atrial fibrillation and atrial flutter.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Dose-Response Relationsh | 1980 |
Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
Topics: Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Double-Blind Method; Electrocardiogra | 1980 |
Verapamil therapy of atrial fibrillation and atrial flutter following cardiac operation.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Cardiac Surgical Procedures; Clini | 1982 |
[Conversion of chronic atrial fibrillation or flutter with disopyramide and a verapamil-quinidine combination: a comparative study ].
Topics: Aged; Atrial Flutter; Disopyramide; Drug Combinations; Female; Humans; Male; Middle Aged; Pyridines; | 1982 |
Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Met | 1981 |
The effect of magnesium versus verapamil on supraventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Female; Heart Rate; Humans; Infusions, In | 1993 |
Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Female; Heart Ra | 1995 |
[Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Doubl | 1999 |
Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil.
Topics: Atrial Fibrillation; Atrial Flutter; Drug Evaluation; Female; Flecainide; Humans; Male; Middle Aged; | 1992 |
Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Female; Flecainide; Hear | 1989 |
Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clini | 1989 |
Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; | 1989 |
Oral verapamil fails to prevent supraventricular tachycardia following coronary artery surgery.
Topics: Administration, Oral; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Coronary Artery | 1985 |
69 other studies available for verapamil and Auricular Flutter
| Article | Year |
|---|---|
Comparative Efficacy and Safety of Intravenous Verapamil and Diltiazem for Rate Control in Rapidly Conducted Atrial Fibrillation and Atrial Flutter.
Topics: Administration, Intravenous; Atrial Fibrillation; Atrial Flutter; Diltiazem; Humans; Verapamil | 2020 |
[Double tachycardia: association of an atrial flutter and a fascicular ventricular tachycardia].
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Catheter Ablation; Electrocardiography; Humans; Male; | 2013 |
Vasospastic angina with J-wave pattern and polymorphic ventricular tachycardia effectively treated with quinidine.
Topics: Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Combined Modality | 2012 |
[Treatment of supraventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter | 1981 |
[Pharmacotherapy of paroxysmal tachycardia].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Disopyramide | 1983 |
[Conservative therapy of supraventricular tachycardias].
Topics: Adrenergic beta-Antagonists; Ajmaline; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; | 1984 |
Electropharmacology of the slow-channel inhibitors in the management of cardiac arrhythmias: verapamil.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Heart Conduction Sys | 1982 |
[Chinidin and verapamil combined against atrial arrhythmias].
Topics: Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Drug Therapy, Combination; Heart | 1982 |
Acute respiratory failure following intravenous verapamil in Duchenne's muscular dystrophy.
Topics: Adolescent; Atrial Flutter; Humans; Ion Channels; Male; Muscular Dystrophies; Respiratory Insufficie | 1983 |
Conversion of longstanding atrial flutter to sinus rhythm and transient complete A-V block following oral administration of verapamil. Report of a case.
Topics: Aged; Atrial Flutter; Electrocardiography; Heart Block; Humans; Male; Myocardial Infarction; Verapam | 1984 |
Advances in the management of cardiac arrhythmias in children.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pa | 1984 |
Verapamil therapy in the treatment of supraventricular arrhythmias following open heart surgery.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Cardiac Surgi | 1983 |
[Combined administration of quinidine and verapamil in chronic atrial fibrillation and atrial flutter (author's transl].
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Drug Combinations; Female; Humans; Male; Middle Ag | 1982 |
Electroversion after verapamil administration.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Female; Humans; | 1983 |
Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Disopyramide; El | 1983 |
[Treatment of paroxysmal forms of auricular fibrillation and atrial flutter in a cardiological hospital].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Glycosides; Drug T | 1983 |
Supraventricular tachycardias.
Topics: Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Diagnosis, Differential; Electric Counte | 1983 |
A hemodynamic complication of verapamil therapy in a neonate.
Topics: Atrial Flutter; Electrocardiography; Hemodynamics; Humans; Infant, Newborn; Infusions, Parenteral; M | 1981 |
Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Blood Gas Analysis; Chronic Disease; Electrocardiography; | 1980 |
Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.
Topics: Administration, Oral; Adult; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Female; Hea | 1980 |
Verapamil or diltiazem for acute rate control: which is best.
Topics: Atrial Fibrillation; Atrial Flutter; Diltiazem; Heart Rate; Humans; Verapamil | 1995 |
Effect of exercise on cycle length in atrial flutter.
Topics: Adult; Atrial Flutter; Digoxin; Electrocardiography; Exercise; Female; Humans; Male; Verapamil | 1995 |
Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter.
Topics: Acute Disease; Administration, Sublingual; Aged; Atrial Fibrillation; Atrial Flutter; Chromatography | 1994 |
[Paroxysmal atrial fibrillation and flutter and "occult" arterial hypertension. The importance of the ambulatory monitoring of the blood pressure. Apropos 2 cases].
Topics: Atenolol; Atrial Fibrillation; Atrial Flutter; Blood Pressure Monitors; Diltiazem; Drug Therapy, Com | 1993 |
Effects of verapamil and diltiazem on the ventricular rate during simulated atrial flutter in isolated guinea pig hearts.
Topics: Animals; Atrial Flutter; Calcium Channel Blockers; Diltiazem; Disease Models, Animal; Electrocardiog | 1996 |
[Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship | 1996 |
Verapamil or diltiazem for acute rate control.
Topics: Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Diltiazem; Heart Rate; Humans; Treatment | 1997 |
Near doubling of heart rate after intravenous verapamil for treatment of atrial fibrillation without preexcitation.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Hea | 1997 |
Efficacy of the novel calcium antagonist R(+)-semotiadil in limiting the ventricular rate during atrial flutter in isolated guinea pig hearts.
Topics: Animals; Atrial Flutter; Atrioventricular Node; Calcium Channel Blockers; Diltiazem; Female; Guinea | 2000 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
[Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Injections, | 1975 |
[Drug therapy of tachycardial heart-rhythm disorders].
Topics: Adrenergic beta-Antagonists; Ajmaline; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; | 1976 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutte | 1978 |
[Verapamil in the treatment of arrhythmias after open-heart surgical operations].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Humans; Post | 1978 |
[Acute treatment with verapamil of paroxysmal supraventricular tachycardia and atrial flutter in paediatric age (author's transl)].
Topics: Age Factors; Atrial Flutter; Child; Child, Preschool; Drug Evaluation; Electrocardiography; Heart Ar | 1979 |
Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Female; Heart Rate; Humans; Male; Middle Aged; Ver | 1979 |
[Effectiveness of treatment of paroxysms of auricular flutter].
Topics: Adult; Aged; Ajmaline; Anti-Arrhythmia Agents; Atrial Flutter; Electric Countershock; Humans; Middle | 1979 |
[Re-evaluation of the use of verapamil in supraventricular tachyarrhythmias].
Topics: Atrial Fibrillation; Atrial Flutter; Electrocardiography; Humans; Tachycardia; Ventricular Fibrillat | 1978 |
[Drug-induced conversion of arterial fibrillation/flutter by a verapamil/quinidine combination].
Topics: Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Humans; Quinidine; Verapamil | 1978 |
[Demonstration of a major preexcitation syndrome during treatment of auricular flutter using intravenous injection of verapamil].
Topics: Adult; Atrial Flutter; Electrocardiography; Humans; Male; Verapamil; Wolff-Parkinson-White Syndrome | 1975 |
[Anti-arrhythmic therapy with verapamil by intravenous infusion].
Topics: Adolescent; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1975 |
Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Blood Pressure; | 1975 |
Clinical experience with verapamil.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Heart Block; Heart C | 1975 |
[Treatment of heart-rhythm disorders in infancy and childhood].
Topics: Age Factors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Chil | 1975 |
[A paroxysm of atrial flutter-fibrillation simulating ventricular tachycardia].
Topics: Acute Disease; Adenosine Triphosphate; Aged; Atrial Fibrillation; Atrial Flutter; Diagnosis, Differe | 1992 |
Short-term control of supraventricular tachycardia with verapamil infusion and calcium pretreatment.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Calcium; Female; Heart Rate; Humans; Infu | 1990 |
[Supraventricular tachyarrhythmia of recent onset in the absence of documented cardiac pathology: different therapeutic approaches].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electric Countershock; | 1989 |
[Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
Topics: Atrial Fibrillation; Atrial Flutter; Digoxin; Drug Therapy, Combination; Female; Heart Rate; Humans; | 1989 |
Hyperthyroid-induced atrial flutter-fibrillation with profound sinoatrial nodal pauses due to small doses of digoxin, verapamil, and propranolol.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digoxin; Female; Humans; Hyperthyroidism; | 1989 |
Fetal atrial flutter and X-linked dominant vitamin D-resistant rickets.
Topics: Adult; Atrial Flutter; Cesarean Section; Digoxin; Drug Therapy, Combination; Electric Countershock; | 1985 |
Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dogs; Female; Male; | 1987 |
Treatment of atrial arrhythmias. Effectiveness of verapamil when preceded by calcium infusion.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Calcium Chloride; Digoxin; Drug Evalua | 1986 |
Supraventricular tachycardia emergencies: diagnosis and management.
Topics: Atrial Fibrillation; Atrial Flutter; Digitalis; Electrocardiography; Electrophysiology; Emergencies; | 1986 |
Supraventricular tachycardias in the emergency room.
Topics: Atrial Fibrillation; Atrial Flutter; Digoxin; Edrophonium; Electric Countershock; Emergencies; Human | 1985 |
Conjunctival oxygen monitoring in atrial flutter.
Topics: Aged; Atrial Flutter; Cardiac Output; Conjunctiva; Humans; Male; Oximetry; Oxygen; Verapamil | 1985 |
Successful management of atrial flutter in a newborn with verapamil.
Topics: Atrial Flutter; Electrocardiography; Humans; Infant, Newborn; Male; Propranolol; Verapamil | 1985 |
[What is assured in the treatment of heart arrhythmia?].
Topics: Adrenergic beta-Antagonists; Ajmaline; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; C | 1972 |
Clinical effects of verapamil in cardiac arrhythmias.
Topics: Adult; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Fema | 1972 |
[The treatment of cardiac arrhythmias: complexity and schematization].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atri | 1973 |
[The treatment of heart arrhythmia with the heart sympatholytic iproveratril].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Com | 1967 |
[Treatment of heart rhythm disorders with beta-receptor-blocking agents].
Topics: Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter | 1968 |
[Use of isoptin in angina pectoris and heart rhythm disorders].
Topics: Adolescent; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibri | 1967 |
[Drug therapy of tachycardiac arrhythmias].
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillatio | 1969 |
[Treatment of tachycardiac arrhythmias in infants and children using Isoptin].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Catheterization; Cardiac Compl | 1969 |
Verapamil in life-threatening tachyarrhythmias.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Output; Electrocardiography; Emer | 1972 |
The use of intravenous verapamil in cardiac arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Humans; Injections, Intraven | 1973 |
[Clinical analysis of the antiarrhythmic effect of Verapamils].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Drug Antagonism; | 1972 |
[The antiarrhythmic action mechanism of verapamil (Isoptin)].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Blood Pressure; Drug Antagonism | 1971 |
[Late results of treating auricular flutter and fibrillation using controlled cardiac phasic electroshock].
Topics: Atrial Fibrillation; Atrial Flutter; Cardiac Glycosides; Electric Countershock; Humans; Premedicatio | 1971 |